National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$162.25
add to cart

Rights & Permissions

topleft topright

Science and Judgment in Risk Assessment (1994)
Board on Environmental Studies and Toxicology (BEST)

Citation Manager

. "References." Science and Judgment in Risk Assessment. Washington, DC: The National Academies Press, 1994.

Please select a format:

BibTeX EndNote RefMan


Page
270
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Page 270

Ames, B.N., and L.S. Gold. 1990b. Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA 87:7772-7776.

Amoco/EPA (U.S. Environmental Protection Agency). 1992. Amoco-U.S. EPA Pollution Prevention Project. Project Summary, Yorktown, Va., and Amoco Corp., Chicago, Ill.

Andersen, M.E. 1991. Quantitative risk assessment and chemical carcinogens in occupational environments. Appl. Ind. Hyg. 3:267-273.

Andersen, M.E., H.J. Clewell III, M.L. Gargas, F.A. Smith, and R.H. Reitz. 1987. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:185-205.

Andersen, M.E., H.J. Clewell III, M.L. Gargas, M.G. MacNaughton, R.H. Reitz, R.J. Nolan, and M.J. McKenna. 1991. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicol. Appl. Pharmacol. 108:14-27.

Anspaugh, L.R., and W.L. Robison. 1968. Quantitative Evaluation of the Biological Hazards of Radiation Associated with Project Ketch. UCID-15325. Biomedical Division, Lawrence Livermore Radiation Laboratory, University of California, Livermore, Calif.

Armitage, P., and R. Doll. 1957. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 11:161-169.

Bacci, E., D. Calamari, C. Gaggi, and M. Vighi. 1990. Bioconcentration of organic chemical vapors in plant leaves: Experimental measurements and correlation. Environ. Sci. Technol. 24:885-889.

Bailar, J.C., III, E.A. Crouch, R. Shaikh, and D. Spiegelman. 1988. One-hit models of carcinogenesis: Conservative or not? Risk Anal. 8:485-497.

Bailar, J.C., III, J. Needleman, B.L. Berney, J.M. McGinnis, and J. Michael. 1993. Determining Risks to Health: Methodological Approaches. Westport, Conn.: Auburn House Publishing.

Barbacid, M. 1986. Mutagens, oncogenes and cancer. Trends Genet. 2:188-192.

Barnes, D.G., and M. Dourson. 1988. Reference dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8:471-486.

Berenbaum, M.C. 1989. What is synergy? Pharmacol. Rev. 41:93-141.

Berry, G., M. Newhouse, and P. Antonis. 1985. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br. J. Ind. Med. 42:12-18.

Bishop, J.M. 1987. The molecular genetics of cancer. Science 235:305-311.

Bogen, K.T. 1989. Cell proliferation kinetics and multistage cancer risk models. J. Natl. Cancer Inst. 81:267-277.

Bogen, K.T. 1990a. Uncertainty in Environmental Health Risk Assessment. New York: Garland Publishing.

Bogen, K.T. 1990b. Risk extrapolation for chlorinated methanes as promoters vs. initiators of multistage carcinogenesis. Fundam. Appl. Toxicol. 15:536-557.

Bogen, K.T., and R.C. Spear. 1987. Integrating uncertainty and interindividual variability in environmental risk assessment. Risk Anal. 7:427-436.

Boughton, B.A., J.M. Delaurentis, and W.E. Dunn. 1987. A stochastic model of particle dispersion in the atmosphere. Boundary-Layer Meteorol. 40:147-163.

Page
270
Front Matter (R1-R16)
Executive Summary (1-15)
1 Introduction (16-22)
Part I Current Approaches to Risk Assessment: 2 Risk Assessment and its Social and Regulatory Contexts (23-42)
3 Exposure Assessment (43-55)
4 Assessment of Toxicity (56-67)
5 Risk Characterization (68-78)
Part II Strategies for Improving Risk Assessment: 6 Default Options (79-105)
7 Models, Methods, and Data (106-143)
8 Data Needs (144-159)
9 Uncertainty (160-187)
10 Variability (188-223)
11 Aggregation (224-242)
Part III Implementation of Findings: 12 Implementation (243-268)
References (269-286)
Appendix A: Risk Assessment Methodologies: EPA (287-350)
Appendix B: EPA Memorandum from Henry Habicht (351-374)
Appendix C: Calculation and Modeling of Exposure (375-382)
Appendix D: Working Paper for Considering Draft Revisions to the U.S. EPA Guidelines for Cancer Risk Assessment (383-448)
Appendix E: Use of Pharmacokinetics to Extrapolate from Animal Data to Humans (449-452)
Appendix F: Uncertainty Analysis of Health Risk Estimates (453-478)
Appendix G: Improvement in Human Health Risk Assessment Utilizing Site- and Chemical-Specific Information: A Case Study (479-502)
Appendix H-1: Some Definitional Concerns About Variability (503-504)
Appendix H-2: Individual Susceptibility Factors (505-514)
Appendix I: Aggregation (515-536)
Appendix J: A Tiered Modeling Approach for Assessing the Risks Due to Sources of Hazardous Air Pollutants (537-582)
Appendix K: Science Advisory Board Memorandum on the Integrated Risk Information System and EPA Response (583-590)
Appendix L: Development of Data Used in Risk Assessment (591-598)
Appendix M: Charge to the Committee (599-600)
Appendix N-1: The Case for (601-628)
Appendix N-2: Making Full Use of Scientific Information in Risk Assessment (629-640)
Index (641-652)